Is Diversification Beneficial in Pairs Trading?

Follow us on LinkedIn

Diversification offers several key benefits in trading and investment. Firstly, it helps to mitigate risk by spreading investments across different assets or asset classes. By diversifying, investors can reduce their exposure to any single investment and minimize the impact of potential losses. Secondly, diversification can enhance portfolio stability and smooth out returns over time. Different assets tend to have varying performance patterns, and by combining them in a portfolio, investors can potentially offset the volatility of one asset with the stability of another. Thirdly, diversification provides opportunities for potential growth and capitalizes on different market conditions. By diversifying, investors can position themselves to benefit from different market scenarios.

But does diversification work in a narrow, niche trading area such as pairs trading?

Reference [1] investigated this issue. It proposed a framework for diversification in pairs trading. Specifically, it proposed asset allocation schemes based on:

  • Mean-Variance analysis,
  • Mean reversion budgeting, and
  • Mean reversion ranking.

The authors pointed out,

We have presented a trading program that dynamically allocates capital to multiple mean reversion trading strategies. The approach is designed for trading multiple pairs in order to achieve diversification effects. Moreover, the dynamic rebalancing is adaptive to the current model estimates and based on the relative performance or path behaviors of the pairs in the portfolio. Our empirical experiments have shown that, for a given set of pairs traded, the allocation method plays a significant role in the success of the diversification framework.

In short, diversification is important and beneficial in pairs trading.

The research results are indeed encouraging as they serve as a motivating factor for further exploration of diversification benefits in specialized trading areas such as statistical and volatility arbitrage. The findings provide impetus to delve deeper into the potential advantages of diversification strategies within these niche domains.

Let us know what you think in the comments below or in the discussion forum.

References

[1] Kiseop Lee, Tim Leung, and Boming Ning, A Diversification Framework for Multiple Pairs Trading Strategies, 2023, Risks 11(5):93

Further questions

What's your question? Ask it in the discussion forum

Have an answer to the questions below? Post it here or in the forum

LATEST NEWSArm CEO Fears Humans Could Lose Control of AI
Arm CEO Fears Humans Could Lose Control of AI

“The thing I worry about most is humans losing capability” over the machines, said  Rene Haas, Chief Executive Officer of Arm Holdings Plc, when asked what keeps him up at night when he thinks about artificial intelligence. “You need some override, some backdoor, some way that the system…

Stay up-to-date with the latest news - click here
LATEST NEWSKim Jong Un might be one of the few world dictators who has been seen crying
Kim Jong Un might be one of the few world dictators who has been seen crying

North Korean leader Kim Jong Un was seen crying on national television during a speech in which he addressed North Korea's declining birthrate.

Stay up-to-date with the latest news - click here
LATEST NEWSChina, Japan trade blame over confrontation near disputed islands
China, Japan trade blame over confrontation near disputed islands
Stay up-to-date with the latest news - click here
LATEST NEWSMusk poll shows X users want U.S. conspiracy theorist Jones' account back
Musk poll shows X users want U.S. conspiracy theorist Jones' account back
Stay up-to-date with the latest news - click here
LATEST NEWSInnate Pharma Presents Positive Results From TELLOMAK Phase 2 Study With Lacutamab in Patients With Sézary Syndrome at ASH 2023
Innate Pharma Presents Positive Results From TELLOMAK Phase 2 Study With Lacutamab in Patients With Sézary Syndrome at ASH 2023

Results confirm promising clinical activity, durable responses and favorable safety of lacutamab in heavily pretreated post-mogamulizumab Sézary Syndrome patients. Virtual KOL event will be held on Tuesday, December 12, 2023 at 7:00AM PST (4:00PM CET) MARSEILLE, France — Innate Pharma SA (Euronext Paris: IPH; Nasdaq:…

Stay up-to-date with the latest news - click here

Leave a Reply